189 related articles for article (PubMed ID: 24395300)
1. Emerging roles of miR-210 and other non-coding RNAs in the hypoxic response.
Huang X; Zuo J
Acta Biochim Biophys Sin (Shanghai); 2014 Mar; 46(3):220-32. PubMed ID: 24395300
[TBL] [Abstract][Full Text] [Related]
2. miR-210: fine-tuning the hypoxic response.
Ivan M; Huang X
Adv Exp Med Biol; 2014; 772():205-27. PubMed ID: 24272361
[TBL] [Abstract][Full Text] [Related]
3. miR-210: More than a silent player in hypoxia.
Devlin C; Greco S; Martelli F; Ivan M
IUBMB Life; 2011 Feb; 63(2):94-100. PubMed ID: 21360638
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of microRNAs in the molecular responses to hypoxia.
Crosby ME; Devlin CM; Glazer PM; Calin GA; Ivan M
Curr Pharm Des; 2009; 15(33):3861-6. PubMed ID: 19925433
[TBL] [Abstract][Full Text] [Related]
5. The role of hypoxia-induced miR-210 in cancer progression.
Dang K; Myers KA
Int J Mol Sci; 2015 Mar; 16(3):6353-72. PubMed ID: 25809609
[TBL] [Abstract][Full Text] [Related]
6. A microRNA component of the hypoxic response.
Kulshreshtha R; Davuluri RV; Calin GA; Ivan M
Cell Death Differ; 2008 Apr; 15(4):667-71. PubMed ID: 18219318
[TBL] [Abstract][Full Text] [Related]
7. Interaction Among Noncoding RNAs, DNA Damage Reactions, and Genomic Instability in the Hypoxic Tumor: Is it Therapeutically Exploitable Practice?
Ray SK; Mukherjee S
Curr Mol Med; 2023; 23(3):200-215. PubMed ID: 35048804
[TBL] [Abstract][Full Text] [Related]
8. Mir-221/222 are promising targets for innovative anticancer therapy.
Di Martino MT; Rossi M; Caracciolo D; Gullà A; Tagliaferri P; Tassone P
Expert Opin Ther Targets; 2016 Sep; 20(9):1099-108. PubMed ID: 26959615
[TBL] [Abstract][Full Text] [Related]
9. The dual role of MiR-210 in the aetiology of cancer: A focus on hypoxia-inducible factor signalling.
Afsar S; Syed RU; Bin Break MK; Alsukaybi RH; Alanzi RA; Alshobrmi AM; Alshagdali NM; Alshammari AD; Alharbi FM; Alshammari AM; Algharbi WF; Albrykan KM; Alshammari FN
Pathol Res Pract; 2024 Jan; 253():155018. PubMed ID: 38070222
[TBL] [Abstract][Full Text] [Related]
10. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing.
Chang YY; Kuo WH; Hung JH; Lee CY; Lee YH; Chang YC; Lin WC; Shen CY; Huang CS; Hsieh FJ; Lai LC; Tsai MH; Chang KJ; Chuang EY
Mol Cancer; 2015 Feb; 14():36. PubMed ID: 25888956
[TBL] [Abstract][Full Text] [Related]
11. Identification of hypoxia-inducible factor-1 alpha as a novel target for miR-17-92 microRNA cluster.
Taguchi A; Yanagisawa K; Tanaka M; Cao K; Matsuyama Y; Goto H; Takahashi T
Cancer Res; 2008 Jul; 68(14):5540-5. PubMed ID: 18632605
[TBL] [Abstract][Full Text] [Related]
12. The Roles of Hypoxia-Inducible Factors and Non-Coding RNAs in Gastrointestinal Cancer.
Cho HS; Han TS; Hur K; Ban HS
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31817259
[TBL] [Abstract][Full Text] [Related]
13. HypoxamiRs and cancer: from biology to targeted therapy.
Gee HE; Ivan C; Calin GA; Ivan M
Antioxid Redox Signal; 2014 Sep; 21(8):1220-38. PubMed ID: 24111776
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based analysis: identification of hypoxia-regulated microRNAs in retinoblastoma cells.
Xu X; Jia R; Zhou Y; Song X; Wang J; Qian G; Ge S; Fan X
Int J Oncol; 2011 May; 38(5):1385-93. PubMed ID: 21373755
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA regulation of DNA repair gene expression in hypoxic stress.
Crosby ME; Kulshreshtha R; Ivan M; Glazer PM
Cancer Res; 2009 Feb; 69(3):1221-9. PubMed ID: 19141645
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs shuttled via exosomes reshape the hypoxic tumor microenvironment.
Wang W; Han Y; Jo HA; Lee J; Song YS
J Hematol Oncol; 2020 Jun; 13(1):67. PubMed ID: 32503591
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-210 expression inhibits proliferation, induces apoptosis and enhances radiosensitivity in hypoxic human hepatoma cells in vitro.
Yang W; Sun T; Cao J; Liu F; Tian Y; Zhu W
Exp Cell Res; 2012 May; 318(8):944-54. PubMed ID: 22387901
[TBL] [Abstract][Full Text] [Related]
18. Multiple functions of hypoxia-regulated miR-210 in cancer.
Qin Q; Furong W; Baosheng L
J Exp Clin Cancer Res; 2014 Jun; 33(1):50. PubMed ID: 24909053
[TBL] [Abstract][Full Text] [Related]
19. Macrophage-derived reactive oxygen species suppress miR-328 targeting CD44 in cancer cells and promote redox adaptation.
Ishimoto T; Sugihara H; Watanabe M; Sawayama H; Iwatsuki M; Baba Y; Okabe H; Hidaka K; Yokoyama N; Miyake K; Yoshikawa M; Nagano O; Komohara Y; Takeya M; Saya H; Baba H
Carcinogenesis; 2014 May; 35(5):1003-11. PubMed ID: 24318997
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression.
Chen Z; Li Y; Zhang H; Huang P; Luthra R
Oncogene; 2010 Jul; 29(30):4362-8. PubMed ID: 20498629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
